Empagliflozin decreases fasting and postprandial hyperglycaemia in totally pancreatectomised patients: a randomised, double-blinded, placebo-controlled study

A. Lund; M. Baekdal; S. W. Nielsen; C. P. Hansen; J. H. Storkholm; B. Hartmann; J. J. Holst; T. Vilsbøll; F. K. Knop

Empagliflozin decreases fasting and postprandial hyperglycaemia in totally pancreatectomised patients: a randomised, double-blinded, placebo-controlled study

A. Lund, M. Baekdal, S. W. Nielsen, C. P. Hansen, J. H. Storkholm, B. Hartmann, J. J. Holst, T. Vilsbøll, F. K. Knop

Research output: Contribution to journal › Conference abstract in journal › Research

Original language	English
Article number	574
Journal	Diabetologia
Volume	63
Issue number	Suppl. 1
Pages (from-to)	S276
Number of pages	1
ISSN	0012-186X
Publication status	Published - 2020
Event	56th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD) - Duration: 21 Sep 2020 → 25 Sep 2020

Conference

Conference	56th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD)
Period	21/09/2020 → 25/09/2020

Access to Document

https://link.springer.com/article/10.1007/s00125-020-05221-5

Cite this

Lund, A., Baekdal, M., Nielsen, S. W., Hansen, C. P., Storkholm, J. H., Hartmann, B., Holst, J. J., Vilsbøll, T., & Knop, F. K. (2020). Empagliflozin decreases fasting and postprandial hyperglycaemia in totally pancreatectomised patients: a randomised, double-blinded, placebo-controlled study. Diabetologia, 63(Suppl. 1), S276. [574]. https://link.springer.com/article/10.1007/s00125-020-05221-5

Empagliflozin decreases fasting and postprandial hyperglycaemia in totally pancreatectomised patients: a randomised, double-blinded, placebo-controlled study. / Lund, A.; Baekdal, M.; Nielsen, S. W.; Hansen, C. P.; Storkholm, J. H.; Hartmann, B.; Holst, J. J.; Vilsbøll, T.; Knop, F. K.

In: Diabetologia, Vol. 63, No. Suppl. 1, 574, 2020, p. S276.

Research output: Contribution to journal › Conference abstract in journal › Research

Lund, A, Baekdal, M, Nielsen, SW, Hansen, CP, Storkholm, JH, Hartmann, B , Holst, JJ , Vilsbøll, T & Knop, FK 2020, 'Empagliflozin decreases fasting and postprandial hyperglycaemia in totally pancreatectomised patients: a randomised, double-blinded, placebo-controlled study', Diabetologia, vol. 63, no. Suppl. 1, 574, pp. S276. <https://link.springer.com/article/10.1007/s00125-020-05221-5>

@article{551130db2e774d8ab10ded2ed47fb50e,

title = "Empagliflozin decreases fasting and postprandial hyperglycaemia in totally pancreatectomised patients: a randomised, double-blinded, placebo-controlled study",

author = "A. Lund and M. Baekdal and Nielsen, {S. W.} and Hansen, {C. P.} and Storkholm, {J. H.} and B. Hartmann and Holst, {J. J.} and T. Vilsb{\o}ll and Knop, {F. K.}",

year = "2020",

language = "English",

volume = "63",

pages = "S276",

journal = "Diabetologia",

issn = "0012-186X",

publisher = "Springer",

number = "Suppl. 1",

note = "56th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD) ; Conference date: 21-09-2020 Through 25-09-2020",

}

TY - ABST

T1 - Empagliflozin decreases fasting and postprandial hyperglycaemia in totally pancreatectomised patients: a randomised, double-blinded, placebo-controlled study

AU - Lund, A.

AU - Baekdal, M.

AU - Nielsen, S. W.

AU - Hansen, C. P.

AU - Storkholm, J. H.

AU - Hartmann, B.

AU - Holst, J. J.

AU - Vilsbøll, T.

AU - Knop, F. K.

PY - 2020

Y1 - 2020

M3 - Conference abstract in journal

VL - 63

SP - S276

JO - Diabetologia

JF - Diabetologia

SN - 0012-186X

IS - Suppl. 1

M1 - 574

T2 - 56th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD)

Y2 - 21 September 2020 through 25 September 2020

ER -